Prosecution Insights
Last updated: November 20, 2026

Brandon William Levy, USPTO Patent Examiner

Listed by the USPTO as LEVY, BRANDON WILLIAM

Tech Center 3700 • Art Units: 3771 3781

This examiner grants 63% of resolved cases

Analysis

LEVY, BRANDON WILLIAM is assigned to Tech Center 3700 and Art Unit 3771. His record includes 197 resolved cases, with a 62.9% allowance rate and a median of 1126 days to allowance. The interview lift is 46.3%, indicating a strong positive association.

The listed companies are The Procter & Gamble Company, Boston Scientific Corporation, and Cilag GmbH International. The listed firms are Bass Patent Law, LLC, HARNESS DICKEY (DETROIT), and ICE MILLER LLP. Practitioners should give interviews a central place in prosecution planning, while using the 1126-day median to manage expectations about time to allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

62.9%
Allow Rate
-7.1% vs TC avg
235
Total Applications
+46.3%
Interview Lift
1126
Avg Prosecution Days
Based on 197 resolved cases, 2023–2026

Rejection Statute Breakdown

1.1%
§101 Eligibility
12.3%
§102 Novelty
56.8%
§103 Obviousness
21.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18950728 ABSORBENT PRODUCTS HAVING IMPROVED PACKAGING EFFICIENCY Final Rejection The Procter & Gamble Company
18514518 RAPID CLOT REMOVAL USING ASPIRATION CATHETER WITH ASPIRATION GUIDED BY MONITORING ASPIRATION PERFORMANCE Non-Final OA ROUTE 92 MEDICAL, INC.
18828523 ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18117044 METHODS AND SYSTEMS FOR THE CALIBRATION, MAINTENANCE, AND SERVICE OF APHERESIS SYSTEMS Final Rejection Terumo BCT, Inc.
18871189 ASPIRATION FLOW CONTROL VALVE Non-Final OA KONINKLIJKE PHILIPS N.V.
17494283 WIRELESS INJECTOR Non-Final OA Alcon Inc.
17044558 DRAINAGE DEVICE AND METHODS Final Rejection UCL BUSINESS LTD.
18842707 NEGATIVE PRESSURE WOUND THERAPY SYSTEM Non-Final OA Solventum Intellectual Properties Company
17312679 ABSORBENT ARTICLES WITH CURVED ELASTICIZED LAMINATES Final Rejection Kimberly-Clark Worldwide, Inc.
19025741 SYSTEMS AND METHODS FOR OPERATING NEGATIVE PRESSURE WOUND THERAPY DEVICES Non-Final OA T.J.Smith and Nephew,Limited
19199269 Catheter Insertion-Tray Systems and Methods Thereof Non-Final OA C. R. Bard, Inc.
18692118 ASPIRATION THROMBECTOMY SYSTEM Non-Final OA MicroVention, Inc.
18740190 CONTAINER FOR FLUID FOR DELIVERY TO A PATIENT Non-Final OA Fresenius Medical Care Holdings, Inc.
18693638 FLUID COLLECTION ASSEMBLIES INCLUDING A POROUS MATERIAL HAVING A FIRST POROUS LAYER, A SECOND POROUS LAYER, AND A SUPPORTING LAYER Non-Final OA PUREWICK CORPORATION
18836843 Absorbent Body and Hygiene Article Non-Final OA LG Chem, Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Brandon William Levy's allowance rate?

62.9% of resolved applications examined by Brandon William Levy were allowed (197 resolved cases), compared with 66.0% across Art Unit 3771 over the last five years.

Does an interview help with examiner Brandon William Levy?

This examiner's interview lift is +46.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Brandon William Levy take to allow a patent?

Applications allowed by Brandon William Levy took 1,126 days on average from filing to allowance.

Which art unit does examiner Brandon William Levy work in?

Brandon William Levy examines applications in Art Unit 3771 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month